Gio Baracco
University of Miami
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Gio Baracco.
Expert Review of Vaccines | 2011
Tirdad T. Zangeneh; Gio Baracco; Jaffar A. Al-Tawfiq
Streptococcus pneumoniae-related infections have a major global impact on healthcare, especially in the developing world, and are considered the number one vaccine-preventable cause of death in children. There are more than 90 pneumococcal serotypes and 46 serogroups. The first capsular polysaccharide pneumococcal vaccine was licensed in the USA in 1977 for individuals older than 2 years of age at high risk for pneumococcal disease. Two decades later, the first 7-valent pneumococcal polysaccharide–protein conjugate vaccine completed the required clinical trials and was introduced as part of the national immunization program of various countries. New-generation vaccines that include emerging serotypes, while maintaining protection against the 7-valent pneumococcal serotypes, have recently been approved. With the addition of these serotypes, the majority of potential pneumococcal serotypes causing invasive disease in most parts of the world could be covered.
Scandinavian Journal of Infectious Diseases | 2007
Vicente F. Corrales-Medina; Ronald Concha; Jacques Simkins; Mayra Sanchez; Gio Baracco
Rapidly growing mycobacteria (RGM) are included in group IV of Runyon’s classification for mycobacteria [1]. Out of the more than 40 species of RGM, only few have clinical relevance. Those with the most significance for human pathology belong to the M. fortuitum, M. chelonae-abscessus, and the M. smegmatis groups [1]. Endocarditis caused by RGM has been reported largely in prosthetic cardiac valves [2]. Native Cardiac Valve Endocarditis caused by these organisms is extremely rare. We describe a case of endocarditis of a native valve caused by M. abscessus.
American Journal of Infection Control | 2015
Gio Baracco; S. Eisert; S. Saavedra; P. Hirsch; M. Marin; I.R. Ortega-Sanchez
BACKGROUND Exposure to patients with varicella or herpes zoster causes considerable disruption to a health care facilitys operations and has a significant health and economic impact. However, practices related to screening for immunity and immunization of health care personnel (HCP) for varicella vary widely. METHODS A decision tree model was built to evaluate the cost-effectiveness of 8 different strategies of screening and vaccinating HCP for varicella. The outcomes are presented as probability of acquiring varicella, economic impact of varicella per employee per year, and cost to prevent additional cases of varicella. Monte Carlo simulations and 1-way sensitivity analyses were performed to address the uncertainties inherent to the model. Alternative epidemiologic and technologic scenarios were also analyzed. RESULTS Performing a clinical screening followed by serologic testing of HCP with negative history diminished the cost impact of varicella by >99% compared with not having a program. Vaccinating HCP with negative screen cost approximately
Infection Control and Hospital Epidemiology | 2018
Lisa Pineles; Chris Petruccelli; Eli N. Perencevich; Mary Claire Roghmann; Kalpana Gupta; Jose Cadena; Gio Baracco; Christopher D. Pfeiffer; Graeme N. Forrest; Suzanne F. Bradley; Chris Crnich; Heather Schacht Reisinger; Daniel J. Morgan
50,000 per case of varicella prevented at the current level of U.S. population immunity, but was projected to be cost-saving at 92% or lower immunity prevalence. Improving vaccine acceptance rates and using highly sensitive assays also optimize cost-effectiveness. CONCLUSION Strategies relying on screening and vaccinating HCP for varicella on employment were shown to be cost-effective for health care facilities and are consistent with current national guidelines for varicella prevention.
Surgical Infections | 2005
Carl I. Schulman; Nicholas Namias; James C. Doherty; Ronald J. Manning; Pamela Li; Ahmed El-Haddad; David Lasko; Jose Amortegui; Christopher J. Dy; Lucie Dlugasch; Gio Baracco; Stephen M. Cohn
OBJECTIVETo directly observe healthcare workers in a nursing home setting to measure frequency and duration of resident contact and infection prevention behavior as a factor of isolation practiceDESIGNObservational studySETTING AND PARTICIPANTSHealthcare workers in 8 VA nursing homes in Florida, Maryland, Massachusetts, Michigan, Washington, and TexasMETHODSOver a 15-month period, trained research staff without clinical responsibilities on the units observed nursing home resident room activity for 15-30-minute intervals. Observers recorded time of entry and exit, isolation status, visitor type (staff, visitor, etc), hand hygiene, use of gloves and gowns, and activities performed in the room when visible.RESULTSA total of 999 hours of observation were conducted across 8 VA nursing homes during which 4,325 visits were observed. Residents in isolation received an average of 4.73 visits per hour of observation compared with 4.21 for nonisolation residents (P<.01), a 12.4% increase in visits for residents in isolation. Residents in isolation received an average of 3.53 resident care activities per hour of observation, compared with 2.46 for residents not in isolation (P<.01). For residents in isolation, compliance was 34% for gowns and 58% for gloves. Healthcare worker hand hygiene compliance was 45% versus 44% (P=.79) on entry and 66% versus 55% (P<.01) on exit for isolation and nonisolation rooms, respectively.CONCLUSIONSHealthcare workers visited residents in isolation more frequently, likely because they required greater assistance. Compliance with gowns and gloves for isolation was limited in the nursing home setting. Adherence to hand hygiene also was less than optimal, regardless of isolation status of residents.Infect Control Hosp Epidemiol 2018;39:683-687.
Surgical Infections | 2007
Ali Hallal; Stephen M. Cohn; Nicholas Namias; Fahim Habib; Gio Baracco; Ronald J. Manning; Bruce Crookes; Carl I. Schulman
Emerging Infectious Diseases | 2009
Lewis J. Radonovich; Paul D. Magalian; Mary Kay Hollingsworth; Gio Baracco
Current Infectious Disease Reports | 1999
Gio Baracco; Alan L. Bisno
American Journal of Infection Control | 2013
Shobha S. Subhash; Gio Baracco; Kevin P. Fennelly; Michael J. Hodgson; Lewis J. Radonovich
Infection Control and Hospital Epidemiology | 2018
Eli N. Perencevich; Anthony D. Harris; Christopher D. Pfeiffer; Michael A. Rubin; Jennifer N. Hill; Gio Baracco; Martin E. Evans; J. Stacey Klutts; Judy A. Streit; Richard E. Nelson; Karim Khader; Heather Schacht Reisinger
Collaboration
Dive into the Gio Baracco's collaboration.
University of Texas Health Science Center at San Antonio
View shared research outputs